Exousia Pro, Inc. (MAJI)
OTCMKTS
· Delayed Price · Currency is USD
0.0285
+0.0013 (4.78%)
Mar 9, 2026, 12:57 PM EST
Exousia Pro Company Description
Exousia Pro, Inc., a clinical stage biotechnology company, develops ways to exploit the therapeutic potential of exosomes for the field of oncology in the United States.
The company was formerly known as Marijuana, Inc. and changed its name to Exousia Pro, Inc. in April 2025.
Exousia Pro, Inc. was incorporated in 2010 and is based in Saint Petersburg, Florida.
Exousia Pro, Inc.
| Country | United States |
| Founded | 2010 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 3 |
| CEO | Donald Steinberg |
Contact Details
Address: 7901 4th Street N #23494 Saint Petersburg, Florida 33702 United States | |
| Phone | 509 605 6533 |
| Website | exousiapro.com |
Stock Details
| Ticker Symbol | MAJI |
| Exchange | OTCMKTS |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US36257K2087 |
| SIC Code | 9995 |
Key Executives
| Name | Position |
|---|---|
| Donald J. Steinberg | Chief Executive Officer and Director |